BioMed Central | Articles which cite: Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. O'Reilly MK, Collins BE, Han S, Liao L, Rillahan C, Kitov PI, Bundle DR, Paulson JC J Am Chem Soc 2008 Jun 18, 130:7736-45 [PubMed Central] [PubMed] [Related articles]
2.	Translating co-stimulation blockade into clinical practice. Westhovens R, Verschueren P Arthritis Res Ther 2008, 10 Suppl 1:S4 [PubMed Central] [PubMed] [Related articles]
3.	Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC, Children's Oncology Group Pilot Study J Clin Oncol 2008 Aug 1, 26:3756-62 [PubMed Central] [PubMed] [Related articles]
4.	B cell modulation in rheumatology. Silverman GJ, Khanna S Curr Opin Pharmacol 2007 Aug, 7:426-33 [PubMed Central] [PubMed] [Related articles]
5.	The future of biologic agents in the treatment of Sjögren's syndrome. Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG Clin Rev Allergy Immunol 2007 Jun, 32:292-7 [PubMed Central] [PubMed] [Related articles]
6.	Biologic treatments for systemic rheumatic diseases. Shirota Y, Illei GG, Nikolov NP Oral Dis 2008 Apr, 14:206-16 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]